Acquiring Broadpath significantly enhances Sagility's foothold within the large and mid-sized U.S. healthcare payer segments. This strategic move adds a Top 10 U.S. payer client to Sagility's roster, expanding its reach to six of the top ten in the country while also granting access to over 30 mid-market clients, diversifying its revenue base. The acquisition also broadens Sagility’s capabilities in Medicare and Medicaid, complementing existing services and reinforcing client needs across the payer value chain. Financially, with approximately US$ 70M in revenues, the deal is expected to be accretive to earnings per share (EPS) from the outset, promising shareholder value through cross-sell synergies and economies of scale. Furthermore, Broadpath’s innovative Bhive platform, which supports a work-from-home model, is anticipated to boost employee engagement and operational efficiencies when combined with Sagility’s GenAI solutions. Overall, this acquisition positions Sagility for robust growth while enhancing its competitive landscape. Positive outlook for investors as shareholder value and client offerings are likely to expand.